Nortis is developing the
next generation of in-vitro systems
that will allow scientists to better understand the causes of human disease.
These systems represent urgently-awaited alternatives to animal testing,
promising to drastically accelerate the discovery of new therapeutic drugs and
the evaluation of toxic substances.
in-vitro systems are based on small
segments of tissues and organs grown from human-derived cells in disposable
chip-like devices. This makes testing compounds faster, cheaper, and most
importantly, more predictive than animal testing. We anticipate that Nortis's
tissue-engineered in-vitro systems
will become essential tools for finding cures for the most debilitating
diseases of our time.